Yuani Uppal

DNP Doctor of Nursing Practice,  Charité - Universitätsmedizin Berlin 

Location: India

Consulting Services

Grant Submission Scientific Writing

Areas Of Interest

Adenitides, Salivary Gland p42(Mapk) Bioterrorism Heart Valve Prolapse Acids, Lysophosphatidic Health Professionals, Allied Bronze Frogs Titanium GT, Immunoglobulin Polyketide Synthases Re Irradiation TCF 4 Transcription Factor Riboside, 6-Mercaptopurine Aqueous-Blood Barrier Landau-Kleffner Syndrome Therapy, X Ray Cascara Sagrada Vacuum Extractions, Obstetric Vegesan Cranial Nerve VI Diseases Myopathy, Proximal Myotonic ATP Citrate (pro-3S)-Lyase Protactinium Cytochrome P 450 Monooxygenase Prospective Pricing Congenital Stiff-Man Syndromes Maljunction, Pancreaticobiliary

Professional Narrative

Dr. Yuani Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Mayo Clinic 2003
Medical Writer, Mayo Clinic 1994

Education

Doctor of osteopathic medicine, Perelman School of Medicine 1996
Master of Science in physician assistant, Harvard Medical School 2007

Referees

Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02